img

Global Cobamamide for Injection Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cobamamide for Injection Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Cobamamide is mainly used for megaloblastic anemia, malnutrition anemia, pregnancy anemia, polyneuritis, radiculopathy, trigeminal neuralgia, sciatica, nerve palsy, it can also be used for nutritional disorders, radiation, and drug-induced leukopenia.
The global Cobamamide for Injection market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Cobamamide for Injection is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Cobamamide for Injection is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Cobamamide for Injection is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Cobamamide for Injection include Haerbin Medisan, North China Pharmaceutical Group, Chongqing Yaoyou Pharmaceutical, Hainan Star Pharmaceutical, Hebei Zhitong Biopharmaceutical, Jiangsu Jiuxu Pharmaceutical and Jiuquan Dadeli pharmaceutical, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Cobamamide for Injection, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Cobamamide for Injection by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Cobamamide for Injection market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Cobamamide for Injection market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Haerbin Medisan
North China Pharmaceutical Group
Chongqing Yaoyou Pharmaceutical
Hainan Star Pharmaceutical
Hebei Zhitong Biopharmaceutical
Jiangsu Jiuxu Pharmaceutical
Jiuquan Dadeli pharmaceutical
By Type
0.5mg
1.0mg
1.5mg
By Application
Hospital
Drug Store
Other
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Cobamamide for Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Cobamamide for Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cobamamide for Injection sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Cobamamide for Injection Definition
1.2 Market by Type
1.2.1 Global Cobamamide for Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 0.5mg
1.2.3 1.0mg
1.2.4 1.5mg
1.3 Market Segment by Application
1.3.1 Global Cobamamide for Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Cobamamide for Injection Sales
2.1 Global Cobamamide for Injection Revenue Estimates and Forecasts 2018-2034
2.2 Global Cobamamide for Injection Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Cobamamide for Injection Revenue by Region
2.3.1 Global Cobamamide for Injection Revenue by Region (2018-2024)
2.3.2 Global Cobamamide for Injection Revenue by Region (2024-2034)
2.4 Global Cobamamide for Injection Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Cobamamide for Injection Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Cobamamide for Injection Sales Quantity by Region
2.6.1 Global Cobamamide for Injection Sales Quantity by Region (2018-2024)
2.6.2 Global Cobamamide for Injection Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Cobamamide for Injection Sales Quantity by Manufacturers
3.1.1 Global Cobamamide for Injection Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Cobamamide for Injection Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Cobamamide for Injection Sales in 2022
3.2 Global Cobamamide for Injection Revenue by Manufacturers
3.2.1 Global Cobamamide for Injection Revenue by Manufacturers (2018-2024)
3.2.2 Global Cobamamide for Injection Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Cobamamide for Injection Revenue in 2022
3.3 Global Cobamamide for Injection Sales Price by Manufacturers
3.4 Global Key Players of Cobamamide for Injection, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Cobamamide for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Cobamamide for Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Cobamamide for Injection, Product Offered and Application
3.8 Global Key Manufacturers of Cobamamide for Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Cobamamide for Injection Sales Quantity by Type
4.1.1 Global Cobamamide for Injection Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Cobamamide for Injection Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Cobamamide for Injection Sales Quantity Market Share by Type (2018-2034)
4.2 Global Cobamamide for Injection Revenue by Type
4.2.1 Global Cobamamide for Injection Historical Revenue by Type (2018-2024)
4.2.2 Global Cobamamide for Injection Forecasted Revenue by Type (2024-2034)
4.2.3 Global Cobamamide for Injection Revenue Market Share by Type (2018-2034)
4.3 Global Cobamamide for Injection Price by Type
4.3.1 Global Cobamamide for Injection Price by Type (2018-2024)
4.3.2 Global Cobamamide for Injection Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Cobamamide for Injection Sales Quantity by Application
5.1.1 Global Cobamamide for Injection Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Cobamamide for Injection Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Cobamamide for Injection Sales Quantity Market Share by Application (2018-2034)
5.2 Global Cobamamide for Injection Revenue by Application
5.2.1 Global Cobamamide for Injection Historical Revenue by Application (2018-2024)
5.2.2 Global Cobamamide for Injection Forecasted Revenue by Application (2024-2034)
5.2.3 Global Cobamamide for Injection Revenue Market Share by Application (2018-2034)
5.3 Global Cobamamide for Injection Price by Application
5.3.1 Global Cobamamide for Injection Price by Application (2018-2024)
5.3.2 Global Cobamamide for Injection Price Forecast by Application (2024-2034)
6 North America
6.1 North America Cobamamide for Injection Sales by Company
6.1.1 North America Cobamamide for Injection Revenue by Company (2018-2024)
6.1.2 North America Cobamamide for Injection Sales Quantity by Company (2018-2024)
6.2 North America Cobamamide for Injection Market Size by Type
6.2.1 North America Cobamamide for Injection Sales Quantity by Type (2018-2034)
6.2.2 North America Cobamamide for Injection Revenue by Type (2018-2034)
6.3 North America Cobamamide for Injection Market Size by Application
6.3.1 North America Cobamamide for Injection Sales Quantity by Application (2018-2034)
6.3.2 North America Cobamamide for Injection Revenue by Application (2018-2034)
6.4 North America Cobamamide for Injection Market Size by Country
6.4.1 North America Cobamamide for Injection Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Cobamamide for Injection Revenue by Country (2018-2034)
6.4.3 North America Cobamamide for Injection Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cobamamide for Injection Sales by Company
7.1.1 Europe Cobamamide for Injection Sales Quantity by Company (2018-2024)
7.1.2 Europe Cobamamide for Injection Revenue by Company (2018-2024)
7.2 Europe Cobamamide for Injection Market Size by Type
7.2.1 Europe Cobamamide for Injection Sales Quantity by Type (2018-2034)
7.2.2 Europe Cobamamide for Injection Revenue by Type (2018-2034)
7.3 Europe Cobamamide for Injection Market Size by Application
7.3.1 Europe Cobamamide for Injection Sales Quantity by Application (2018-2034)
7.3.2 Europe Cobamamide for Injection Revenue by Application (2018-2034)
7.4 Europe Cobamamide for Injection Market Size by Country
7.4.1 Europe Cobamamide for Injection Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Cobamamide for Injection Revenue by Country (2018-2034)
7.4.3 Europe Cobamamide for Injection Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Cobamamide for Injection Sales by Company
8.1.1 China Cobamamide for Injection Sales Quantity by Company (2018-2024)
8.1.2 China Cobamamide for Injection Revenue by Company (2018-2024)
8.2 China Cobamamide for Injection Market Size by Type
8.2.1 China Cobamamide for Injection Sales Quantity by Type (2018-2034)
8.2.2 China Cobamamide for Injection Revenue by Type (2018-2034)
8.3 China Cobamamide for Injection Market Size by Application
8.3.1 China Cobamamide for Injection Sales Quantity by Application (2018-2034)
8.3.2 China Cobamamide for Injection Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Cobamamide for Injection Sales by Company
9.1.1 APAC Cobamamide for Injection Sales Quantity by Company (2018-2024)
9.1.2 APAC Cobamamide for Injection Revenue by Company (2018-2024)
9.2 APAC Cobamamide for Injection Market Size by Type
9.2.1 APAC Cobamamide for Injection Sales Quantity by Type (2018-2034)
9.2.2 APAC Cobamamide for Injection Revenue by Type (2018-2034)
9.3 APAC Cobamamide for Injection Market Size by Application
9.3.1 APAC Cobamamide for Injection Sales Quantity by Application (2018-2034)
9.3.2 APAC Cobamamide for Injection Revenue by Application (2018-2034)
9.4 APAC Cobamamide for Injection Market Size by Region
9.4.1 APAC Cobamamide for Injection Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Cobamamide for Injection Revenue by Region (2018-2034)
9.4.3 APAC Cobamamide for Injection Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Cobamamide for Injection Sales by Company
10.1.1 Middle East, Africa and Latin America Cobamamide for Injection Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Cobamamide for Injection Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Cobamamide for Injection Market Size by Type
10.2.1 Middle East, Africa and Latin America Cobamamide for Injection Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Cobamamide for Injection Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Cobamamide for Injection Market Size by Application
10.3.1 Middle East, Africa and Latin America Cobamamide for Injection Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Cobamamide for Injection Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Cobamamide for Injection Market Size by Country
10.4.1 Middle East, Africa and Latin America Cobamamide for Injection Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Cobamamide for Injection Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Cobamamide for Injection Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Haerbin Medisan
11.1.1 Haerbin Medisan Company Information
11.1.2 Haerbin Medisan Overview
11.1.3 Haerbin Medisan Cobamamide for Injection Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Haerbin Medisan Cobamamide for Injection Products and Services
11.1.5 Haerbin Medisan Cobamamide for Injection SWOT Analysis
11.1.6 Haerbin Medisan Recent Developments
11.2 North China Pharmaceutical Group
11.2.1 North China Pharmaceutical Group Company Information
11.2.2 North China Pharmaceutical Group Overview
11.2.3 North China Pharmaceutical Group Cobamamide for Injection Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 North China Pharmaceutical Group Cobamamide for Injection Products and Services
11.2.5 North China Pharmaceutical Group Cobamamide for Injection SWOT Analysis
11.2.6 North China Pharmaceutical Group Recent Developments
11.3 Chongqing Yaoyou Pharmaceutical
11.3.1 Chongqing Yaoyou Pharmaceutical Company Information
11.3.2 Chongqing Yaoyou Pharmaceutical Overview
11.3.3 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Products and Services
11.3.5 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection SWOT Analysis
11.3.6 Chongqing Yaoyou Pharmaceutical Recent Developments
11.4 Hainan Star Pharmaceutical
11.4.1 Hainan Star Pharmaceutical Company Information
11.4.2 Hainan Star Pharmaceutical Overview
11.4.3 Hainan Star Pharmaceutical Cobamamide for Injection Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Hainan Star Pharmaceutical Cobamamide for Injection Products and Services
11.4.5 Hainan Star Pharmaceutical Cobamamide for Injection SWOT Analysis
11.4.6 Hainan Star Pharmaceutical Recent Developments
11.5 Hebei Zhitong Biopharmaceutical
11.5.1 Hebei Zhitong Biopharmaceutical Company Information
11.5.2 Hebei Zhitong Biopharmaceutical Overview
11.5.3 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Products and Services
11.5.5 Hebei Zhitong Biopharmaceutical Cobamamide for Injection SWOT Analysis
11.5.6 Hebei Zhitong Biopharmaceutical Recent Developments
11.6 Jiangsu Jiuxu Pharmaceutical
11.6.1 Jiangsu Jiuxu Pharmaceutical Company Information
11.6.2 Jiangsu Jiuxu Pharmaceutical Overview
11.6.3 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Products and Services
11.6.5 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection SWOT Analysis
11.6.6 Jiangsu Jiuxu Pharmaceutical Recent Developments
11.7 Jiuquan Dadeli pharmaceutical
11.7.1 Jiuquan Dadeli pharmaceutical Company Information
11.7.2 Jiuquan Dadeli pharmaceutical Overview
11.7.3 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Products and Services
11.7.5 Jiuquan Dadeli pharmaceutical Cobamamide for Injection SWOT Analysis
11.7.6 Jiuquan Dadeli pharmaceutical Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Cobamamide for Injection Value Chain Analysis
12.2 Cobamamide for Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cobamamide for Injection Production Mode & Process
12.4 Cobamamide for Injection Sales and Marketing
12.4.1 Cobamamide for Injection Sales Channels
12.4.2 Cobamamide for Injection Distributors
12.5 Cobamamide for Injection Customers
13 Market Dynamics
13.1 Cobamamide for Injection Industry Trends
13.2 Cobamamide for Injection Market Drivers
13.3 Cobamamide for Injection Market Challenges
13.4 Cobamamide for Injection Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Cobamamide for Injection Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of 0.5mg
Table 3. Major Manufacturers of 1.0mg
Table 4. Major Manufacturers of 1.5mg
Table 5. Global Cobamamide for Injection Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Cobamamide for Injection Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Cobamamide for Injection Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Cobamamide for Injection Revenue Market Share by Region (2018-2024)
Table 9. Global Cobamamide for Injection Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Cobamamide for Injection Revenue Market Share by Region (2024-2034)
Table 11. Global Cobamamide for Injection Sales Quantity by Region: 2018 VS 2022 VS 2034 (Kg)
Table 12. Global Cobamamide for Injection Sales by Region (2018-2024) & (Kg)
Table 13. Global Cobamamide for Injection Sales Market Share by Region (2018-2024)
Table 14. Global Cobamamide for Injection Sales by Region (2024-2034) & (Kg)
Table 15. Global Cobamamide for Injection Sales Market Share by Region (2024-2034)
Table 16. Global Cobamamide for Injection Sales Quantity by Manufacturers (2018-2024) & (Kg)
Table 17. Global Cobamamide for Injection Sales Quantity Share by Manufacturers (2018-2024)
Table 18. Global Cobamamide for Injection Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Cobamamide for Injection Revenue Share by Manufacturers (2018-2024)
Table 20. Global Cobamamide for Injection Price by Manufacturers 2018-2024 (US$/g)
Table 21. Global Key Players of Cobamamide for Injection, Industry Ranking, 2021 VS 2022
Table 22. Global Cobamamide for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Cobamamide for Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cobamamide for Injection as of 2022)
Table 24. Global Key Manufacturers of Cobamamide for Injection, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Cobamamide for Injection, Product Offered and Application
Table 26. Global Key Manufacturers of Cobamamide for Injection, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cobamamide for Injection Sales Quantity by Type (2018-2024) & (Kg)
Table 29. Global Cobamamide for Injection Sales Quantity by Type (2024-2034) & (Kg)
Table 30. Global Cobamamide for Injection Sales Quantity Share by Type (2018-2024)
Table 31. Global Cobamamide for Injection Sales Quantity Share by Type (2024-2034)
Table 32. Global Cobamamide for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Cobamamide for Injection Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Cobamamide for Injection Revenue Share by Type (2018-2024)
Table 35. Global Cobamamide for Injection Revenue Share by Type (2024-2034)
Table 36. Cobamamide for Injection Price by Type (2018-2024) & (US$/g)
Table 37. Global Cobamamide for Injection Price Forecast by Type (2024-2034) & (US$/g)
Table 38. Global Cobamamide for Injection Sales Quantity by Application (2018-2024) & (Kg)
Table 39. Global Cobamamide for Injection Sales Quantity by Application (2024-2034) & (Kg)
Table 40. Global Cobamamide for Injection Sales Quantity Share by Application (2018-2024)
Table 41. Global Cobamamide for Injection Sales Quantity Share by Application (2024-2034)
Table 42. Global Cobamamide for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Cobamamide for Injection Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Cobamamide for Injection Revenue Share by Application (2018-2024)
Table 45. Global Cobamamide for Injection Revenue Share by Application (2024-2034)
Table 46. Cobamamide for Injection Price by Application (2018-2024) & (US$/g)
Table 47. Global Cobamamide for Injection Price Forecast by Application (2024-2034) & (US$/g)
Table 48. North America Cobamamide for Injection Revenue by Company (2018-2024) & (US$ Million)
Table 49. North America Cobamamide for Injection Sales Quantity by Company (2018-2024) & (Kg)
Table 50. North America Cobamamide for Injection Sales Quantity by Type (2018-2024) & (Kg)
Table 51. North America Cobamamide for Injection Sales Quantity by Type (2024-2034) & (Kg)
Table 52. North America Cobamamide for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 53. North America Cobamamide for Injection Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Cobamamide for Injection Sales Quantity by Application (2018-2024) & (Kg)
Table 55. North America Cobamamide for Injection Sales Quantity by Application (2024-2034) & (Kg)
Table 56. North America Cobamamide for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 57. North America Cobamamide for Injection Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Cobamamide for Injection Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 59. North America Cobamamide for Injection Revenue by Country (2018-2024) & (US$ Million)
Table 60. North America Cobamamide for Injection Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Cobamamide for Injection Sales Quantity by Country (2018-2024) & (Kg)
Table 62. North America Cobamamide for Injection Sales Quantity by Country (2024-2034) & (Kg)
Table 63. Europe Cobamamide for Injection Sales Quantity by Company (2018-2024) & (Kg)
Table 64. Europe Cobamamide for Injection Revenue by Company (2018-2024) & (US$ Million)
Table 65. Europe Cobamamide for Injection Sales Quantity by Type (2018-2024) & (Kg)
Table 66. Europe Cobamamide for Injection Sales Quantity by Type (2024-2034) & (Kg)
Table 67. Europe Cobamamide for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 68. Europe Cobamamide for Injection Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Cobamamide for Injection Sales Quantity by Application (2018-2024) & (Kg)
Table 70. Europe Cobamamide for Injection Sales Quantity by Application (2024-2034) & (Kg)
Table 71. Europe Cobamamide for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 72. Europe Cobamamide for Injection Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Cobamamide for Injection Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 74. Europe Cobamamide for Injection Revenue by Country (2018-2024) & (US$ Million)
Table 75. Europe Cobamamide for Injection Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Cobamamide for Injection Sales Quantity by Country (2018-2024) & (Kg)
Table 77. Europe Cobamamide for Injection Sales Quantity by Country (2024-2034) & (Kg)
Table 78. China Cobamamide for Injection Sales Quantity by Company (2018-2024) & (Kg)
Table 79. China Cobamamide for Injection Revenue by Company (2018-2024) & (US$ Million)
Table 80. China Cobamamide for Injection Sales Quantity by Type (2018-2024) & (Kg)
Table 81. China Cobamamide for Injection Sales Quantity by Type (2024-2034) & (Kg)
Table 82. China Cobamamide for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 83. China Cobamamide for Injection Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Cobamamide for Injection Sales Quantity by Application (2018-2024) & (Kg)
Table 85. China Cobamamide for Injection Sales Quantity by Application (2024-2034) & (Kg)
Table 86. China Cobamamide for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 87. China Cobamamide for Injection Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Cobamamide for Injection Sales Quantity by Company (2018-2024) & (Kg)
Table 89. APAC Cobamamide for Injection Revenue by Company (2018-2024) & (US$ Million)
Table 90. APAC Cobamamide for Injection Sales Quantity by Type (2018-2024) & (Kg)
Table 91. APAC Cobamamide for Injection Sales Quantity by Type (2024-2034) & (Kg)
Table 92. APAC Cobamamide for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 93. APAC Cobamamide for Injection Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Cobamamide for Injection Sales Quantity by Application (2018-2024) & (Kg)
Table 95. APAC Cobamamide for Injection Sales Quantity by Application (2024-2034) & (Kg)
Table 96. APAC Cobamamide for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 97. APAC Cobamamide for Injection Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Cobamamide for Injection Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 99. APAC Cobamamide for Injection Revenue by Region (2018-2024) & (US$ Million)
Table 100. APAC Cobamamide for Injection Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Cobamamide for Injection Sales Quantity by Region (2018-2024) & (Kg)
Table 102. APAC Cobamamide for Injection Sales Quantity by Region (2024-2034) & (Kg)
Table 103. Middle East, Africa and Latin America Cobamamide for Injection Sales Quantity by Company (2018-2024) & (Kg)
Table 104. Middle East, Africa and Latin America Cobamamide for Injection Revenue by Company (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Cobamamide for Injection Sales Quantity by Type (2018-2024) & (Kg)
Table 106. Middle East, Africa and Latin America Cobamamide for Injection Sales Quantity by Type (2024-2034) & (Kg)
Table 107. Middle East, Africa and Latin America Cobamamide for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Cobamamide for Injection Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Cobamamide for Injection Sales Quantity by Application (2018-2024) & (Kg)
Table 110. Middle East, Africa and Latin America Cobamamide for Injection Sales Quantity by Application (2024-2034) & (Kg)
Table 111. Middle East, Africa and Latin America Cobamamide for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America Cobamamide for Injection Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Cobamamide for Injection Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Cobamamide for Injection Revenue by Country (2018-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Cobamamide for Injection Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Cobamamide for Injection Sales Quantity by Country (2018-2024) & (Kg)
Table 117. Middle East, Africa and Latin America Cobamamide for Injection Sales Quantity by Country (2024-2034) & (Kg)
Table 118. Haerbin Medisan Company Information
Table 119. Haerbin Medisan Description and Overview
Table 120. Haerbin Medisan Cobamamide for Injection Sales Quantity (Kg), Revenue (US$ Million), Average Selling Price (ASP) (US$/g) and Gross Margin (2018-2024)
Table 121. Haerbin Medisan Cobamamide for Injection Product and Services
Table 122. Haerbin Medisan Cobamamide for Injection SWOT Analysis
Table 123. Haerbin Medisan Recent Developments
Table 124. North China Pharmaceutical Group Company Information
Table 125. North China Pharmaceutical Group Description and Overview
Table 126. North China Pharmaceutical Group Cobamamide for Injection Sales Quantity (Kg), Revenue (US$ Million), Average Selling Price (ASP) (US$/g) and Gross Margin (2018-2024)
Table 127. North China Pharmaceutical Group Cobamamide for Injection Product and Services
Table 128. North China Pharmaceutical Group Cobamamide for Injection SWOT Analysis
Table 129. North China Pharmaceutical Group Recent Developments
Table 130. Chongqing Yaoyou Pharmaceutical Company Information
Table 131. Chongqing Yaoyou Pharmaceutical Description and Overview
Table 132. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales Quantity (Kg), Revenue (US$ Million), Average Selling Price (ASP) (US$/g) and Gross Margin (2018-2024)
Table 133. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Product and Services
Table 134. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection SWOT Analysis
Table 135. Chongqing Yaoyou Pharmaceutical Recent Developments
Table 136. Hainan Star Pharmaceutical Company Information
Table 137. Hainan Star Pharmaceutical Description and Overview
Table 138. Hainan Star Pharmaceutical Cobamamide for Injection Sales Quantity (Kg), Revenue (US$ Million), Average Selling Price (ASP) (US$/g) and Gross Margin (2018-2024)
Table 139. Hainan Star Pharmaceutical Cobamamide for Injection Product and Services
Table 140. Hainan Star Pharmaceutical Cobamamide for Injection SWOT Analysis
Table 141. Hainan Star Pharmaceutical Recent Developments
Table 142. Hebei Zhitong Biopharmaceutical Company Information
Table 143. Hebei Zhitong Biopharmaceutical Description and Overview
Table 144. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales Quantity (Kg), Revenue (US$ Million), Average Selling Price (ASP) (US$/g) and Gross Margin (2018-2024)
Table 145. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Product and Services
Table 146. Hebei Zhitong Biopharmaceutical Cobamamide for Injection SWOT Analysis
Table 147. Hebei Zhitong Biopharmaceutical Recent Developments
Table 148. Jiangsu Jiuxu Pharmaceutical Company Information
Table 149. Jiangsu Jiuxu Pharmaceutical Description and Overview
Table 150. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales Quantity (Kg), Revenue (US$ Million), Average Selling Price (ASP) (US$/g) and Gross Margin (2018-2024)
Table 151. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Product and Services
Table 152. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection SWOT Analysis
Table 153. Jiangsu Jiuxu Pharmaceutical Recent Developments
Table 154. Jiuquan Dadeli pharmaceutical Company Information
Table 155. Jiuquan Dadeli pharmaceutical Description and Overview
Table 156. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales Quantity (Kg), Revenue (US$ Million), Average Selling Price (ASP) (US$/g) and Gross Margin (2018-2024)
Table 157. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Product and Services
Table 158. Jiuquan Dadeli pharmaceutical Cobamamide for Injection SWOT Analysis
Table 159. Jiuquan Dadeli pharmaceutical Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Cobamamide for Injection Distributors List
Table 163. Cobamamide for Injection Customers List
Table 164. Cobamamide for Injection Market Trends
Table 165. Cobamamide for Injection Market Drivers
Table 166. Cobamamide for Injection Market Challenges
Table 167. Cobamamide for Injection Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Cobamamide for Injection Product Picture
Figure 2. Global Cobamamide for Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Cobamamide for Injection Market Share by Type in 2022 & 2034
Figure 4. 0.5mg Product Picture
Figure 5. 1.0mg Product Picture
Figure 6. 1.5mg Product Picture
Figure 7. Global Cobamamide for Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Cobamamide for Injection Market Share by Application in 2022 & 2034
Figure 9. Hospital
Figure 10. Drug Store
Figure 11. Other
Figure 12. Cobamamide for Injection Report Years Considered
Figure 13. Global Cobamamide for Injection Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Cobamamide for Injection Revenue 2018-2034 (US$ Million)
Figure 15. Global Cobamamide for Injection Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Cobamamide for Injection Sales Quantity 2018-2034 (Kg)
Figure 17. Global Cobamamide for Injection Sales Quantity Market Share by Region (2018-2024)
Figure 18. Global Cobamamide for Injection Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Cobamamide for Injection Sales Quantity YoY (2018-2034) & (Kg)
Figure 20. North America Cobamamide for Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Cobamamide for Injection Sales Quantity YoY (2018-2034) & (Kg)
Figure 22. Europe Cobamamide for Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Cobamamide for Injection Sales Quantity YoY (2018-2034) & (Kg)
Figure 24. China Cobamamide for Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Cobamamide for Injection Sales Quantity YoY (2018-2034) & (Kg)
Figure 26. APAC Cobamamide for Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Cobamamide for Injection Sales Quantity YoY (2018-2034) & (Kg)
Figure 28. Middle East, Africa and Latin America Cobamamide for Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Cobamamide for Injection Sales Quantity in 2022
Figure 30. The Top 10 and Top 5 Players Market Share by Cobamamide for Injection Revenue in 2022
Figure 31. Cobamamide for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Cobamamide for Injection Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Cobamamide for Injection Revenue Market Share by Type (2018-2034)
Figure 34. Global Cobamamide for Injection Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Cobamamide for Injection Revenue Market Share by Application (2018-2034)
Figure 36. North America Cobamamide for Injection Revenue Market Share by Company in 2022
Figure 37. North America Cobamamide for Injection Sales Quantity Market Share by Company in 2022
Figure 38. North America Cobamamide for Injection Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Cobamamide for Injection Revenue Market Share by Type (2018-2034)
Figure 40. North America Cobamamide for Injection Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Cobamamide for Injection Revenue Market Share by Application (2018-2034)
Figure 42. North America Cobamamide for Injection Revenue Share by Country (2018-2034)
Figure 43. North America Cobamamide for Injection Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Cobamamide for Injection Sales Quantity Market Share by Company in 2022
Figure 47. Europe Cobamamide for Injection Revenue Market Share by Company in 2022
Figure 48. Europe Cobamamide for Injection Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Cobamamide for Injection Revenue Market Share by Type (2018-2034)
Figure 50. Europe Cobamamide for Injection Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Cobamamide for Injection Revenue Market Share by Application (2018-2034)
Figure 52. Europe Cobamamide for Injection Revenue Share by Country (2018-2034)
Figure 53. Europe Cobamamide for Injection Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 55. France Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 59. China Cobamamide for Injection Sales Quantity Market Share by Company in 2022
Figure 60. China Cobamamide for Injection Revenue Market Share by Company in 2022
Figure 61. China Cobamamide for Injection Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Cobamamide for Injection Revenue Market Share by Type (2018-2034)
Figure 63. China Cobamamide for Injection Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Cobamamide for Injection Revenue Market Share by Application (2018-2034)
Figure 65. APAC Cobamamide for Injection Sales Quantity Market Share by Company in 2022
Figure 66. APAC Cobamamide for Injection Revenue Market Share by Company in 2022
Figure 67. APAC Cobamamide for Injection Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Cobamamide for Injection Revenue Market Share by Type (2018-2034)
Figure 69. APAC Cobamamide for Injection Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Cobamamide for Injection Revenue Market Share by Application (2018-2034)
Figure 71. APAC Cobamamide for Injection Revenue Share by Region (2018-2034)
Figure 72. APAC Cobamamide for Injection Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 77. India Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Cobamamide for Injection Sales Quantity Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Cobamamide for Injection Revenue Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Cobamamide for Injection Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Cobamamide for Injection Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Cobamamide for Injection Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Cobamamide for Injection Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Cobamamide for Injection Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Cobamamide for Injection Revenue Share by Country (2018-2034)
Figure 86. Brazil Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Cobamamide for Injection Revenue (2018-2034) & (US$ Million)
Figure 91. Cobamamide for Injection Value Chain
Figure 92. Cobamamide for Injection Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed